Both GW - Search Results

1

Recent progress in gene-directed enzyme prodrug therapy: an emerging cancer treatment.

Both GW. Both GW. Curr Opin Mol Ther. 2009 Aug;11(4):421-32. Curr Opin Mol Ther. 2009. PMID: 19649987 Review.

2

Calcitonin-specific transcription and splicing targets gene-directed enzyme prodrug therapy to medullary thyroid carcinoma cells.

Messina M, Yu DM, Both GW, Molloy PL, Robinson BG. Messina M, et al. Among authors: both gw. J Clin Endocrinol Metab. 2003 Mar;88(3):1310-8. doi: 10.1210/jc.2002-021501. J Clin Endocrinol Metab. 2003. PMID: 12629124

3

Transcription-targeted gene therapy for androgen-independent prostate cancer.

Martiniello-Wilks R, Tsatralis T, Russell P, Brookes DE, Zandvliet D, Lockett LJ, Both GW, Molloy PL, Russell PJ. Martiniello-Wilks R, et al. Among authors: both gw. Cancer Gene Ther. 2002 May;9(5):443-52. doi: 10.1038/sj.cgt.7700451. Cancer Gene Ther. 2002. PMID: 11961667

4

Gene-directed enzyme prodrug therapy for cancer: a glimpse into the future?

Both GW. Both GW. Discov Med. 2009 Oct;8(42):97-103. Discov Med. 2009. PMID: 19833053 Free article. Review.

5

Production and release testing of ovine atadenovirus vectors.

Both GW, Cameron F, Collins A, Lockett LJ, Shaw J. Both GW, et al. Methods Mol Med. 2007;130:69-90. doi: 10.1385/1-59745-166-5:69. Methods Mol Med. 2007. PMID: 17401165

6

Purine nucleoside phosphorylase and fludarabine phosphate gene-directed enzyme prodrug therapy suppresses primary tumour growth and pseudo-metastases in a mouse model of prostate cancer.

Martiniello-Wilks R, Wang XY, Voeks DJ, Dane A, Shaw JM, Mortensen E, Both GW, Russell PJ. Martiniello-Wilks R, et al. Among authors: both gw. J Gene Med. 2004 Dec;6(12):1343-57. doi: 10.1002/jgm.629. J Gene Med. 2004. PMID: 15493036

7

Gene-directed enzyme prodrug therapy for prostate cancer in a mouse model that imitates the development of human disease.

Martiniello-Wilks R, Dane A, Voeks DJ, Jeyakumar G, Mortensen E, Shaw JM, Wang XY, Both GW, Russell PJ. Martiniello-Wilks R, et al. Among authors: both gw. J Gene Med. 2004 Jan;6(1):43-54. doi: 10.1002/jgm.474. J Gene Med. 2004. PMID: 14716676

8

Ovine atadenovirus: a review of its biology, biosafety profile and application as a gene delivery vector.

Both GW. Both GW. Immunol Cell Biol. 2004 Apr;82(2):189-95. doi: 10.1046/j.0818-9641.2004.01223.x. Immunol Cell Biol. 2004. PMID: 15061773

9

Preclinical evaluation of a prostate-targeted gene-directed enzyme prodrug therapy delivered by ovine atadenovirus.

Wang XY, Martiniello-Wilks R, Shaw JM, Ho T, Coulston N, Cooke-Yarborough C, Molloy PL, Cameron F, Moghaddam M, Lockett TJ, Webster LK, Smith IK, Both GW, Russell PJ. Wang XY, et al. Among authors: both gw. Gene Ther. 2004 Nov;11(21):1559-67. doi: 10.1038/sj.gt.3302308. Gene Ther. 2004. PMID: 15343359

10

Gene therapy for prostate cancer delivered by ovine adenovirus and mediated by purine nucleoside phosphorylase and fludarabine in mouse models.

Voeks D, Martiniello-Wilks R, Madden V, Smith K, Bennetts E, Both GW, Russell PJ. Voeks D, et al. Among authors: both gw. Gene Ther. 2002 Jun;9(12):759-68. doi: 10.1038/sj.gt.3301698. Gene Ther. 2002. PMID: 12040457

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results